Aspirin Use for Preeclampsia Prevention Among Women With Prepregnancy Diabetes, Obesity, and Hypertension.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35076678.
- Also identified by DOI 10.1001/jama.2021.22749 and PMC identifier 8790661.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study estimates aspirin use for preeclampsia prevention in pregnant women with prepregnancy diabetes, obesity, chronic hypertension, and combinations of these factors in 2018-2020.
Medical subject headings
- Aspirin
- Hypertension
- Obesity
- Pre-Eclampsia
- Pregnancy Complications
- Pregnancy in Diabetics